Concepedia

Antonio Cuevas-Navarro

AC

10

Publications

1.2K

Citations

10

H-Index

2016

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

UCSF Helen Diller Family Comprehensive Cancer Center

Leidos (United States)

University of California, San Francisco

Antonio Cuevas-Navarro is an author at Memorial Sloan Kettering Cancer Center specializing in cell signaling, signal transduction, and medicine.

ORCID

Top concepts

Publications per year

2016–2024

10

Publications

10

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth

Dong-Sung Kim, Lorenz Herdeis, Dorothea Rudolph et al. · Nature · 2023 · 448 citations · Full text

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text

Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS

Christopher J. Schulze, Kyle J. Seamon, Yulei Zhao et al. · Science · 2023 · 203 citations · Full text

RIT1 oncoproteins escape LZTR1-mediated proteolysis

Pau Castel, Alice Cheng, Antonio Cuevas-Navarro et al. · Science · 2019 · 117 citations · Full text

RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity

Pau Castel, Srisathiyanarayanan Dharmaiah, Matthew J. Sale et al. · Proceedings of the National Academy of Sciences · 2021 · 38 citations · Full text

, , +12

Rows per page

1–5 of 10